AssayIndex
JEEP cross-section

JEEP by compound

JEEP records split by compound, with the index-wide comparison for the same compound beside each one. 24 compounds, 230 records. Cells below n=3 print their raw values instead of a median.

24 compounds230 records
CompoundClassReportsJEEP median %Index median %Δ (pp)SpecPass %
BPC-157Tissue-repair2999.0999.16-0.0798.0100
SemaglutideIncretin2599.2498.89+0.3597.0100
TB-500Tissue-repair2199.6899.53+0.1598.5100
TirzepatideIncretin1998.8698.55+0.3197.0100
SemaxNeuroactive1899.5399.46+0.0798.5100
SS-31 (Elamipretide)Metabolic1499.6699.53+0.1398.5100
Melanotan IIMelanocortin-receptor1399.5099.42+0.0898.5100
RetatrutideIncretin1397.9298.37-0.4596.5100
GHRP-6Growth-hormone1399.4299.54-0.1299.0100
PT-141 (Bremelanotide)Melanocortin-receptor1298.4499.38-0.9498.533
N-Acetyl Semax AmideNeuroactive1099.9399.35+0.5898.5100
5-Amino-1MQNon-peptide999.9399.45+0.4898.0100
LiraglutideIncretin6 n=699.0999.00+0.0997.5100
CJC-1295 with DACGrowth-hormone4 n=498.7398.95-0.2297.5100
MOTS-cMetabolic4 n=499.5699.13+0.4398.0100
KPVTissue-repair4 n=499.8599.64+0.2199.0100
ARA-290Tissue-repair3 n=399.2499.42-0.1898.0100
LeuprolideHypothalamic3 n=399.3299.28+0.0498.5100
HexarelinGrowth-hormone2 n=2n<399.5999.0100
ThymulinTissue-repair2 n=2n<399.2798.0100
GHRP-2Growth-hormone2 n=2n<399.2899.0100
EpitalonShort2 n=2n<399.5699.0100
CagrilintideIncretin1 n=1n<398.6996.5100
PinealonShort1 n=1n<399.9399.0100
97.698.098.498.899.399.7100.1BPC-157BPC-157: Q1 98.85, median 99.09, Q3 99.24, n=29n=29SemaglutideSemaglutide: Q1 99.03, median 99.24, Q3 99.38, n=25outlier 99.93n=25TB-500TB-500: Q1 99.47, median 99.68, Q3 99.93, n=21n=21TirzepatideTirzepatide: Q1 98.65, median 98.86, Q3 99.12, n=19n=19SemaxSemax: Q1 99.49, median 99.53, Q3 99.72, n=18outlier 99.07n=18SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 99.22, median 99.66, Q3 99.69, n=14n=14Melanotan IIMelanotan II: Q1 99.40, median 99.50, Q3 99.72, n=13n=13RetatrutideRetatrutide: Q1 97.85, median 97.92, Q3 98.42, n=13n=13GHRP-6GHRP-6: Q1 99.33, median 99.42, Q3 99.50, n=13outlier 99.04n=13PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 98.31, median 98.44, Q3 98.72, n=12n=12N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 99.83, median 99.93, Q3 99.93, n=10n=105-Amino-1MQ5-Amino-1MQ: Q1 99.78, median 99.93, Q3 99.93, n=9outlier 99.35n=9LiraglutideLiraglutide: Q1 99.04, median 99.09, Q3 99.26, n=6outlier 98.71n=6CJC-1295 with DACCJC-1295 with DAC: Q1 98.62, median 98.73, Q3 98.96, n=4outlier 99.52n=4 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines JEEP actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Guangzhou JEEP Biotechnology Co., Ltd. lists considerably more than the 24 compounds above. Of those 24, 16 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the JEEP catalogue at jeepbio.com →